SCHEMBL8358064

SCHEMBL8358064

ClCc1ccnc(N2CCOCC2)c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CA P42336 2/20 0.54
LRRK2 Q5S007 2/20 0.45
OPRM1 P35372 1/20 0.44
OPRL1 P41146 1/20 0.44
PIK3CB P42338 1/20 0.44
SMG1 Q96Q15 3/20 0.43
CYP1A2 P05177 1/20 0.43
CYP2D6 P10635 1/20 0.43
MAPT P10636 1/20 0.43
OGA O60502 1/20 0.43
HTT P42858 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
ELOVL1 Q9BW60 1/20 0.42
HCRTR1 O43613 1/20 0.42
HCRTR2 O43614 1/20 0.42
CYP2C19 P33261 1/20 0.42
ABL1 P00519 1/20 0.41
CNR2 P34972 1/20 0.41
CDK1 P06493 1/20 0.41
CDK2 P24941 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3742630 0.84 PIK3CA (0.57) PIK3CALRRK2PIK3CBABL1KMO
SCHEMBL5718308 0.84 PIK3CA (0.54) PIK3CALRRK2OPRM1OPRL1PIK3CB
SCHEMBL2459118 0.84 PIK3CA (0.54) PIK3CALRRK2OPRM1OPRL1PIK3CB
SCHEMBL8197483 0.84 PIK3CA (0.59) PIK3CALRRK2OPRM1OPRL1PIK3CB
SCHEMBL15504891 0.83 HRH4 (0.50) OPRM1OPRL1CYP1A2SMN1; SMN2ELOVL1
SCHEMBL10210050 0.83 PIK3CA (0.50) PIK3CALRRK2PIK3CBSMG1MAPT
SCHEMBL13069962 0.81 PIK3CA (0.53) PIK3CALRRK2OPRM1OPRL1PIK3CB
SCHEMBL8228263 0.80 LRRK2 (0.56) PIK3CALRRK2OPRM1OPRL1PIK3CB
SCHEMBL10154083 0.80 PIK3CA (0.50) PIK3CALRRK2OPRM1OPRL1PIK3CB
SCHEMBL13028832 0.80 PIK3CA (0.50) PIK3CALRRK2OPRM1OPRL1PIK3CB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7598242-B2 Compounds for the treatment of inflammatory disorders SCHERING CORPORATION (US) 2009-10-06 US disclosed
US-7598242-B2 Compounds for the treatment of inflammatory disorders SCHERING CORPORATION (US) 2009-10-06 US disclosed
WO-2003053915-A2 COMPOUNDS FOR THE TREATMENT OF INFLAMMATORY DISORDERS SCHERING CORPORATION (US) 2003-07-03 WO disclosed